Denali Therapeutics Inc.

151 Oyster Point Boulevard
South San Francisco
United States


NextGen Class of 2017
Show jobs for this employer

About Denali Therapeutics Inc.

Denali Therapeutics Inc. is a privately held biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Located in South San Francisco, Denali was founded by Drs. Marc Tessier-Lavigne, Ryan Watts, Alex Schuth and investors who share the vision that recent scientific insights in genetics, biology and translational medicine offer an unprecedented opportunity to discover and develop effective medicines for neurodegenerative disease. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include ARCH Venture Partners, F-Prime Biosciences, Flagship Ventures and the Alaska Permanent Fund.
Founder and CEO: Ryan Watts
Founder and COO: Alexander Schuth
Founder: Marc Tessier-Lavigne
CMO: Carole Ho
CFO: Steve Krognes
Please click here for Denali job opportunities.

72 articles with Denali Therapeutics Inc.